Getty Images Health Novo Nordisk launches Ozempic in India as type 2 diabetes and obesity cases surge Pooja PillaiDec 12, 2025
Health Novo Nordisk shares nosedive as Mounjaro, copycat weight loss drugs threaten market lead Gayathri Kallukaran30 July
Health New weight-loss pill Amycretin shows greater impact than jabs, study finds Gayathri Kallukaran21 June
iStock Health Eli Lilly's Zepbound outshines Wegovy in weight loss trial results Gayathri KallukaranMay 12, 2025
Health Eli Lilly introduces Mounjaro in India, gaining an edge over Novo Nordisk in the weight-loss drug market Gayathri KallukaranMar 21, 2025